Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for cancer and autoimmune disease.
86 employees · est. 2020 · Cambridge, United States
Repertoire Immune Medicines is the older company (2021 vs 2020); Repertoire Immune Medicines is the larger of the two.
Side-by-Side Comparison
| Metric | Omniscope | Repertoire Immune Medicines |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2020 older |
| Headquarters | ||
| Headquarters | Palo Alto, United States | Cambridge, United States |
| Employees | ||
| Employees | 39 | 86 larger |
| Industry | ||
| Industry | AI, Big Data, Biotechnology | Biotechnology, Health and Wellness, Life Sciences |
| Funding Stage | ||
| Funding Stage | Growth | Series B |
| Total Funding | ||
| Total Funding | $6.75M | $189.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 2 |
| Services | ||
| Services | Immune system exploration, Performance boosting, Healthspan optimization, Therapy engineering, Scientific publications, Consultancy services | Discovery of Immune Codes, Development of Targeted Immune Medicines, Therapeutic Solutions for Cancer, Therapeutic Solutions for Autoimmune Diseases |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Healthcare providers, Sports professionals, Aging research institutions, Oncologists, Pediatric cancer specialists, Research and academia | Patients with Cancer, Patients with Autoimmune Diseases, Healthcare Providers, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Immune Databank, Immune Cell Sequencing, Diagnostics, Therapy, Precision Medicine, Biomedical Technology, Innovation, Multidisciplinary Collaboration, Human Impact, Technology | Immune Medicines, Cancer Treatment, Autoimmune Disease Treatment, T Cell Repertoire, Immune Synapse, DECODE Platform, T Cell Receptor-epitope Pairs, Immune-based Medicines, Clinical Stage Biotechnology, Autologous T Cell Therapy, IL-15 Tethering, Infectious Disease Treatment, Immune System Innovation, Phenotype Analysis |
| Website | ||
| Website | omniscope.ai | repertoire.com |
About Omniscope
Omniscope, founded in 2021, is pioneering the convergence of AI and Big Data with Biotechnology to establish the world's largest immune databank. This innovative company is utilizing high-resolution immune cell sequencing coupled with artificial intelligence to accelerate therapy development and dia...
About Repertoire Immune Medicines
Repertoire Immune Medicines is at the forefront of developing a new wave of immune medicines, leveraging its expertise in the biotechnology sector. Founded in 2020 and headquartered in the United States, the company uniquely harnesses the potential of the human T cell repertoire to combat cancer, ta...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Omniscope and Repertoire Immune Medicines — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Omniscope and Repertoire Immune Medi... — by email.
Frequently Asked Questions
Compare Omniscope with someone else
Start typing a company name or domain.